-
CuriRx Launches the Advanced Bioprocessing and Analytical Center
contractpharma
January 26, 2022
New center allows the CDMO to further support biotherapeutic drug developers.
-
Mindset Pharma Enters CDMO Manufacturing Agreement
contractpharma
January 26, 2022
Partners with leading CDMO to produce pharmaceutical grade batches of next-generation psilocybin drug candidate, MSP-1014.
-
Recro Signs Development and Manufacturing Deal with U.S. Government
contractpharma
January 26, 2022
The contract involves supporting the clinical development of a topical dermal treatment for the prevention of skin cancer.
-
Cyxone Inks API Deal with European CDMO
contractpharma
January 20, 2022
Takes next step in multiple sclerosis program engaging CDMO for production of drug candidate T20K.
-
Treadwell Therapeutics and CDMO Genezen Enter Cell Therapy Partnership
contractpharma
January 20, 2022
Will advance Treadwell’s T cell receptor-based cell therapy pipeline.
-
Formulated Solutions Expands CDMO Capabilities
contractpharma
January 20, 2022
Installs nasal spray blending and filling suites at its headquarters in Largo, FL.
-
Recro Pharma Appoints Head of Quality for San Diego Ops
contractpharma
January 19, 2022
Eduardo Uribe brings more than 30 years of experience developing, implementing and managing quality systems in the pharma and biopharma industries.
-
AGC Biologics Appoints GM at Boulder Facility
contractpharma
January 19, 2022
Regina Choi-Rivera brings more than 25 years of experience in the biotech industry.
-
Vetter Receives Manufacturing Authorization for New Site
contractpharma
January 19, 2022
First customer audits already completed.
-
Recipharm streamlines operations by selling oral solid dosage manufacturing site
CPhIonline
January 14, 2022
Astrea Pharma will be the new owner of the facility at Fontaine-lès-Dijon.